NCT02712866 |
|
Early Biomarkers in Circulating α 4β7 T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients
|
View
|
NCT02741362 |
|
Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis Systemic Lupus Erythematosus or Sharps Syndrome
|
View
|
NCT03625635 |
|
Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment
|
View
|
NCT04133506 |
|
PGE2IL-22 Pathway in Various Forms of Eczema
|
View
|
NCT05570513 |
|
Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity
|
View
|
NCT05649683 |
|
Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors
|
View
|
NCT04367441 |
|
Randomized Double Blinded Placebo Controlled Single Dose Escalation Study of 608 in Healthy Subjects
|
View
|
NCT01861288 |
|
Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease
|
View
|
NCT05984394 |
|
Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease
|
View
|
NCT06111963 |
|
Role of Inflammatory Markers in Sepsis
|
View
|
NCT06326073 |
|
Interaction Between Smoking GCF Periostin IL17A IL17E and Non-surgical Periodontal Therapy
|
View
|
NCT03310320 |
|
Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis
|
View
|